2024 年至 2031 年血液分离市场规模（按产品、流程、技术、应用、最终用户和地区划分）

血液分离术市场规模及预测 2024-2031

由于血液相关疾病的盛行率不断上升以及对治疗性血液分离手术的需求不断增加，血液分离市场正在经历显着增长。此外，血液采集设备和一次性用品的技术进步正在提高治疗效果并促进市场扩大。因此，预计 2024 年市场规模将超过 39.9 亿美元，2031 年将达到约 63 亿美元。

市场正在全球扩张，其中北美是主要地区。关键推动因素包括增加医疗保健投资和提高对治疗性血液分离术的认识。随着患者人数不断增加以及医疗保健基础设施不断改善，亚太地区的新兴市场也正在获得发展动力。在白血球分离术需求不断增长的推动下，预计 2024 年至 2031 年期间市场复合年增长率为 12.6%。

定义/概述

血液分离术是一种用于分离和去除某些血液成分（例如血浆、血小板和白血球）并将剩余血液送回给患者的医疗程序。

血液分离术广泛用于治疗自体免疫疾病、血液疾病和心血管疾病。它还支持捐血，包括血浆和血小板采集，改善各种临床环境中的患者护理。

由于技术进步、医疗保健基础设施的扩大以及对血液成分治疗的需求不断增加（尤其是在新兴市场），预计未来血液分离市场将会成长。

血液相关疾病的增加将如何推动血液白血球分离术市场的成长？

自体免疫疾病、血液系统恶性肿瘤和心血管疾病等血液相关疾病的发生率不断增加，推动了血液白血病产业的发展。这些疾病经常需要治疗特定的血液成分，从而增加了透过血液分离和回收目标血液成分的单采程序的需求。此外，血液分离技术的创新和医疗保健专业人员对这些程序的好处的认识不断提高，正在推动市场扩张。增加对血液白血球分离技术研究和开发的投资将扩大治疗选择并改善患者的治疗效果。此外，老年人口的增加使得他们更容易患血液疾病，这也推动了对有效的血液分离治疗的需求，从而促进了市场的成长。整体而言，血液相关疾病的盛行率不断上升是血液白血球分离术市场发展的主要驱动力。

血液分离手术的高成本如何对血液分离市场的成长构成课题？

血液白血球分离术的高成本是市场扩张的一大阻碍因素。这些治疗通常需要专门的设备、专门的人员和大量的医院资源，从而增加营运成本。因此，许多医疗保健提供者不愿投资血液分离技术，从而减少了患者接受治疗的机会。此外，高昂的成本会对个人和医疗保健系统造成压力，特别是在保险覆盖和财政资源有限的地区。这种高成本障碍可能会阻止患者选择白血球分离术，从而减少市场需求。此外，来自更廉价的替代疗法的竞争可能会阻碍血液白血球分离术市场的成长。总体而言，血液白血球分离手术的高成本对该行业的长期成长构成了重大障碍。

目录

第 1 章简介

• 市场定义
• 市场区隔
• 研究方法

第 2 章执行摘要

• 主要发现 市场概况
• 市场亮点

第三章 市场概览

• 市场规模与成长潜力
• 市场趋势
• 市场推动因素
• 市场限制
• 市场机会
• 波特五力分析

第 4 章。

• 医院和诊所
• 血库和输血中心
• 门诊手术中心

第 5 章。

• 离心
• 薄膜过滤

第 6 章 血液分离市场（依应用）

• 治疗性血液分离术
• 捐赠者血液分离术

第 7 章 区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利 亚太地区
• 中国
• 日本
• 印度
• 澳大利亚
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合大公国

第 8 章 市场动态

• 市场推动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第 9 章 竞争格局

• 大型公司
• 市占率分析

第十章 公司简介

• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Terumo Corporation
• B. Braun Melsungen AG
• Asahi Kasei Corporation
• Cerus Corporation
• Kawasumi Laboratories, Inc.
• HemaCare Corporation
• Kaneka Corporation
• Grifols, S.A.

第 11 章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第 12 章附录

• 缩写列表
• 来源与参考文献

Apheresis Market Size And Forecast 2024-2031

The Apheresis Market is witnessing significant growth due to rising incidences of blood-related disorders and the increasing demand for therapeutic apheresis procedures. Technological advancements in apheresis devices and disposables are also contributing to the market's expansion, enhancing treatment efficacy. This is likely to enable the market size to surpass USD 3.99 Billion valued in 2024 to reach a valuation of around USD 6.3 Billion by 2031.

The market is expanding globally, with North America as the leading region. Key drivers include increasing healthcare investments and rising awareness of therapeutic apheresis. Emerging markets in Asia-Pacific are also gaining traction, driven by growing patient populations and improving healthcare infrastructure. The rising demand for apheresis is enabling the market to grow at aCAGR of 12.6% from 2024 to 2031.

Definition/Overview

Apheresis is a medical procedure used to separate and remove specific blood components, such as plasma, platelets, or white blood cells, while returning the remaining blood to the patient.

Apheresis is widely used in treating autoimmune disorders, hematological diseases and cardiovascular conditions. It also supports blood donations, including plasma and platelet collection, improving patient care in various clinical settings.

The apheresis market is poised for future growth, driven by advancements in technology, expanding healthcare infrastructure and increasing demand for blood component therapies, particularly in emerging markets.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How Does the Rising Prevalence of Blood-Related Disorders Help in Driving the Growth Of The Apheresis Market?

The increasing frequency of blood-related ailments, such as autoimmune diseases, hematologic malignancies, and cardiovascular problems, is driving the apheresis industry. As these conditions frequently necessitate particular blood component therapy, the demand for apheresis procedures, which separate and collect targeted blood components, grows. Furthermore, innovations in apheresis technology and increasing awareness among healthcare professionals about the benefits of these procedures help to drive market expansion. Increasing investment in apheresis research and development expands treatment options and improves patient outcomes. Furthermore, the growing geriatric population, which is more sensitive to blood problems, increases the demand for effective apheresis treatments, driving market growth. Overall, the increasing prevalence of blood-related illnesses is a significant driver of the apheresis market.

How Is the High Cost of Apheresis Procedures Challenging the Growth Of The Apheresis Market?

The high cost of apheresis operations significantly limits the market's expansion. These treatments frequently necessitate specialized equipment, expert personnel, and substantial hospital resources, resulting in increasing operating expenses. As a result, many healthcare providers may hesitant to invest in apheresis technology, reducing patient access to these treatments. Furthermore, the high costs can put a strain on individuals and healthcare systems, particularly in areas with limited insurance coverage or financial resources. This expensive barrier may prevent patients from choosing for apheresis, reducing market demand. Furthermore, competition from less expensive alternative treatments may impede the apheresis market's growth. Overall, the high prices of apheresis operations represent a significant barrier to long-term industry growth.

Category-wise Acumens

How Will the Increasing Adoption of Automated Technologies Drive the Growth of The Apheresis Devices Segment?

The increasing adoption of automated technologies in apheresis devices is driving the growth of the segment by enhancing procedure accuracy, reducing manual errors and improving patient outcomes. These advanced devices offer greater efficiency in blood component separation, leading to their widespread use in both therapeutic and donation settings. As healthcare providers prioritize automation for better results and time savings, the demand for apheresis devices continues to grow, boosting the market segment's expansion.

How Will the Rising Use of Apheresis in Treating Autoimmune Disorders Drive the Growth of The Application Segment?

The rising use of apheresis in treating autoimmune disorders is driving growth in the Application segment by providing effective, targeted therapies for conditions like multiple sclerosis and Guillain-Barre syndrome. Apheresis helps remove harmful antibodies or immune complexes, offering significant clinical benefits. As the prevalence of autoimmune diseases increases, the demand for apheresis treatments expands, leading to the growth of this segment in both therapeutic and healthcare applications.

Country/Region-wise Acumens

Will The Advanced Healthcare Infrastructure Drive the Dominance of North America in The Apheresis Market?

North America's advanced healthcare infrastructure contributes significantly to the region's supremacy in the apheresis market. The well-established healthcare infrastructure make it easier to integrate innovative technologies, resulting in more efficient apheresis processes. Significant investments in cutting-edge medical technology improve the efficacy and accessibility of these therapies. Furthermore, growing awareness of the therapeutic benefits of apheresis, particularly for autoimmune diseases and hematologic disorders, is broadening the patient base. The region also benefits from a strong research climate, which promotes advances in apheresis technology. Additionally, regulatory backing and increasing healthcare expenditure help to drive market expansion. These factors combine to establish North America as a market leader in apheresis, fueling its sustained growth.

Will The Growing Healthcare Investments and Expanding Patient Population Drive the Rapid Growth of Asia-Pacific in The Apheresis Market?

The growing healthcare investments and expanding patient population are key drivers of Asia-Pacific's rapid growth in the Apheresis Market. As countries like China and India enhance their healthcare infrastructure, demand for advanced therapeutic procedures increases. Additionally, the rising prevalence of blood-related disorders and increasing awareness of apheresis treatments fuel market expansion. This combination of factors is positioning Asia-Pacific as the fastest-growing region in the global apheresis market.

Competitive Landscape

The apheresis market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the Apheresis market include:

Asahi Kasei Corporation

Braun Melsungen AG

Cerus Corporation

Fresenius Kabi

Haemonetics Corporation

Charles River Laboratories International, Inc.

Kaneka Corporation

Kawasumi Laboratories Inc.

Nikkiso Co. Ltd

Terumo BCT

Latest Developments

In September 2024, Fresenius Kabi announced the divestment of its IV manufacturing site in Chile to Medifarma, streamlining its production network as part of its Vision 2026 strategy.

In June 2024, Asahi Kasei Corporation introduced a new membrane system for the production of sterile water used in injections, enhancing its product offerings in the healthcare sector.

In August 2023, Terumo BCT, Inc. launched a training program initiative aimed at supporting cell and gene therapy manufacturers, which is expected to improve cell collection processes and boost therapeutic commercialization.

In March 2024, Haemonetics Corporation received FDA approval for its new apheresis device designed to enhance the efficiency of blood component collection, marking a significant advancement in their product line.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Apheresis Market, By End User

• Hospitals and Clinics
• Blood banks and transfusion centers
• Ambulatory Surgical Centers

5. Apheresis Market, By Technology

• Centrifugation
• Membrane filtering

6. Apheresis Market, By Application

• Therapeutic apheresis
• Donor Apheresis

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Terumo Corporation
• B. Braun Melsungen AG
• Asahi Kasei Corporation
• Cerus Corporation
• Kawasumi Laboratories, Inc.
• HemaCare Corporation
• Kaneka Corporation
• Grifols, S.A.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References